Zuanic & Associates

Post Cannabis Rescheduling: What's Next For Marijuana Giants? Potential $1.1B Cash Flow Boost From IRS 280E Removal
Gold Flora's Strategic Cannabis Blueprint: 30% In-House Sales Boost, Profits, EBITDA Rise
NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?
Gold Flora's Strategic Cannabis Blueprint: 30% In-House Sales Boost, Profits, EBITDA Rise
NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?
Florida's $6B Cannabis Market Anticipates 400% Growth Following Court Decision Allowing Nov. Legalization Ballot
Next-Level Investing: Navigating Europe's Cannabis Surge

Zuanic & Associates Recent News

Flip Your Pre-Roll: 50-50 Odds It's Crafted By This Weed Company Dominating Half Of Canada's Market
In Canada, there's a 50-50 chance that the pre-roll lighting up your day is made by one company: Decibel. Infused pre-rolls have ignited a fiery growth trend, with Decibel stoking the flames and reigning supreme as the king of pre-rolls.
Touchdown In Las Vegas: Exploring Nevada's Cannabis Field, Market And Companies Ahead Of Super Bowl LVIII
As Super Bowl LVIII readies to get underway at Allegiant Stadium in Las Vegas this Sunday, Nevada's cannabis industry, underpinned by recent legislative reforms and strategic positioning, is set to capitalize on the influx of visitors.
Illinois Weed Scorecard, Super Bowl Edition: Market Leaders, Store Surge And Sales Analysis
Illinois' booming cannabis market is under the microscope in Pablo Zuanic's latest report from Zuanic & Associates. With dispensary numbers on the rise, how are multi-state operators (MSOs) adapting amidst political changes and industry buzz?
A Flavor Hunter's Paradise, Canada's Vape Market Skyrockets As Weed Industry Titans Cash In
Pablo Zuanic, senior analyst at Zuanic & Associates delves into Canada's cannabis vape market, looking at its diversity and growth driven by evolving consumer preferences and regulatory shifts.
Biden's Weed Promise, The Federal Govt. & 2024 Elections: Analyzing Stock Values, Taxes & Timing
Amidst President Joe Biden’s campaign promises, rescheduling marijuana from Schedule I to Schedule III is seen as the most impactful on the stock market, possibly positively fueling stock rallies.
Weed Galaxy Watch: Analysis Of Planet 13's Stock Potential, Vision Amid $22M Cash Adjustment
A $22 million cash adjustment and a delayed Florida VidaCann deal for Planet 13 Holdings Inc. (OTC: PLNH) are key points in Pablo Zuanic's latest report from Zuanic & Associates.
A Top Weed Stock Under The Radar: Strong Growth, Cash Flow Savings And Low-Value Market Position
Zuanic & Associates' senior analyst Pablo Zuanic offers a detailed analysis of MariMed Inc. (OTC: MRMD), underscoring its promising trajectory in the cannabis sector and its potential to become a top Multi-State Operator (MSO).
2024 Oscars Of Marijuana Equity: Analyst Nominations Spotlight Key State Performers
In his latest cannabis sector equity report, senior analyst Pablo Zuanic of Zuanic & Associates offers a detailed examination of the cannabis sector's landscape in the fourth quarter of 2023.
Marijuana Rescheduling, Stock Market Reactions: Analyst Insights On Who Wins & Possible Trump Election
The anticipated shift of cannabis to Schedule III marks a pivotal moment for U.S. cannabis companies.
Who's Leading, What's Happening & When It Starts: Analyst Unpacks Virginia's Cannabis Market
Virginia's impending recreational cannabis market, as analyzed by Pablo Zuanic from Zuanic & Associates, points to a promising start for medical incumbents.
Undervalued Cannabis Stock? This Company Could Reach A C$1B Valuation On The Back Of Pre-Roll Sales
With a nearly 50% share in infused pre-rolls, which constitute 70% of its sales, Decibel Cannabis Co. Inc. (TSXV: DB) (OTC: DBCCF) is well-positioned in the market.
Switching From Tomatoes To Cost-Efficient Cannabis Boosts Company's Stock By 35%
Zuanic & Associates has initiated coverage on Village Farms International (NASDAQ: VFF), assigning an "Overweight" rating.
California's Top Cannabis Brands In 2023: Insights Into Market Leadership, Trends
Key findings from a recent equity research report by Pablo Zuanic, a senior analyst at Zuanic & Associates, shed light on the challenges and opportunities facing California's cannabis sector, including competitive dynamics, market trends, and the performance of leading cannabis brands in the state.
A 2024 Investor Guide To New York's Cannabis Market Expansion: The MSO Wealth Roadmap
Considering the significant growth potential in New York's cannabis market and the strategic positioning of Multi-State Operators (MSOs) highlighted in Zuanic & Associate's latest report, how might investors capitalize on
How Much Do Canadians Spend On Marijuana? A Look At Third Quarter 2023 Sales Data
Five years into its legalization, the Canadian cannabis market reveals intriguing regional disparities and growth trends, as highlighted in the latest report from cannabis equity research firm Zuanic & Associates. Despite the usual market drivers like affordability, access, and variety, Canada emerges as an outlier.
Analyst Highlights Asset-Backed Cannabis Loans In Chicago Atlantic's REFI With Overweight Rating
Zuanic & Associates (Z&A) recently initiated coverage of Chicago Atlantic Real Estate Finance Inc. (NASDAQ: REFI) with an Overweight rating.  Chicago Atlantic is an externally managed commercial mortgage real estate investment trust.
Investment Potential: Financial Performance, Portfolio And Growth Of Leading Public Sale-Leaseback Stock In Cannabis
Zuanic & Associates' latest report, which initiates coverage of New Lake Capital Partners (OTC: NLCP) with an Overweight rating explains their motivation. "As of the third quarter of 2023, its net real estate assets were valued at $375 million, a significant increase from $12
Cannabis Vape, Pre-Roll Market Soars: Canada Sees Double-Digit Growth in Q3 2023
Vape products in Canada's cannabis sector demonstrated significant year-over-year growth in Q3 2023, increasing by 21% and ranking third behind pre-rolls at (+25%) and concentrates at (+43%).
EBITDA Growth And Multi-State Opportunities In Key States Going Legal: Zuanic & Associates' Insights
Zuanic & Associates' latest report offers a thorough analysis of the financial impacts expected in key U.S. states, including Florida, Minnesota, Ohio, Pennsylvania and Virginia, as they move toward recreational cannabis sales by 2025.
This Cannabis Stock Poised To Excel Even Without Federal Weed Reform, Posts Q3 Results
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) reported its third-quarter earnings report on Thursday for the three months ended Sept. 30, 2023.
Verano Holdings' 13-State Cannabis Footprint & Solid Balance Sheet Is Undervalued, Expert Explains
Equity research firm Zuanic & Associates, led by senior analyst Pablo Zuanic, has initiated coverage of cannabis company Verano Holdings Corp.(OTC: VRNOF) with an Overweight rating.
TILT's Bull vs. Bear Case: EBITDA Potential In Its Cannabis Business - Analyst Insights
Zuanic & Associates (Z&A), an equity research firm has initiated coverage of TILT Holdings (OTC: TLLTF), a micro-cap stock with a $12 million market cap, with an Overweight rating.
High Capex, High Rewards: Analyst Looks At Cannabis MSOs' Strategies
As interest rates climb and regulatory uncertainties loom, decisions on capital expenditures (capex) by cannabis MSOs (Multi-State Operators) become paramount for their future success.